mcas and tirzepatide A newly published case series reports that GLP-1 receptor agonists (like semaglutide tirzepatide) may significantly improve symptoms in patients with mast cell activation syndrome (MCAS), even in those without diabetes or My experience using Tirzepatide with

Indianapolis: Eli Lily and Company

In insulin-treated patients, disordered gastric emptying, even when not associated with gastrointestinal symptoms, can cause a mismatch between the onset of insulin action and the availability of absorbed carbohydrate, leading to suboptimal glycaemic control

doi:10.1073/pnas.1205227109 44

They were first discovered in the venom of the Gila monster after scientists grew curious about the reptiles ability to eat just a few times a year

It may also have benefits on the brain-gut axis

This dual mechanism not only supports weight loss but also helps manage blood sugar levels, reducing the likelihood of developing high blood pressure and other metabolic conditions